Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,536
Total Claims
$1.6M
Drug Cost
757
Beneficiaries
$2,167
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-49%
Opioid rate vs peers
1.1% vs 2.2% avg
+54%
Cost per patient vs peers
$2,167 vs $1,411 avg
+27%
Brand preference vs peers
13.5% vs 10.6% avg
Opioid Prescribing
1.1%
Opioid Rate
166
Opioid Claims
$967
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,948 claims · $1.3M
Generic: 12,463 claims · $302K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 161 | $213K |
| Apixaban | 271 | $196K |
| Semaglutide | 87 | $94K |
| Empagliflozin | 58 | $73K |
| Sitagliptin Phosphate | 55 | $54K |
| Tirzepatide | 37 | $44K |
| Fluticasone/Umeclidin/Vilanter | 50 | $39K |
| Dapagliflozin Propanediol | 32 | $37K |
| Insulin Glargine,hum.Rec.Anlog | 51 | $36K |
| Insulin Detemir | 52 | $35K |
| Sitagliptin Phos/Metformin Hcl | 31 | $34K |
| Rivaroxaban | 36 | $33K |
| Semaglutide | 16 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 37 | $29K |
| Mirabegron | 38 | $28K |
Prescribing Profile
Patient Profile
73
Avg Age
55%
Female
1.37
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About